Yangzijiang Pharmaceutical Group Nanjing Hailing Pharmaceutical

Nanjing Hailing Pharmaceutical is a core subsidiary of the Yangzijiang Pharmaceutical Group, established in 2001 and located in the Nanjing Jiangning Development Zone. The company operates as a comprehensive pharmaceutical entity integrating research and development, large-scale manufacturing, and commercial distribution. Its therapeutic focus spans anti-infectives, oncology supportive care, cardiovascular health, and gastroenterology. Nanjing Hailing is recognized for its high-standard production facilities, which maintain multiple GMP certifications and have received national accolades for quality management. As a key driver of its parent group's innovation strategy, the company continues to develop and market a wide range of essential medicines for the Chinese and global markets.